Clinical trial
Rett Syndrome, MECP2 Duplication, and Rett-Related Disorders Consortium, Rare Disease Clinical Research Network: Neurophysiologic Correlates
NCT03077308 is registered in ClinicalTrials.gov with University of Alabama at Birmingham as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Rett Syndrome, MECP2 Duplication, and Rett-Related Disorders Consortium, Rare Disease Clinical Research Network: Neurophysiologic Correlates
- Lead sponsor
- University of Alabama at Birmingham
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 2, 2017
- Completion date
- July 31, 2021
- Enrollment
- 185 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
mecp2 duplication syndrome, rett syndrome, preserved speech variant, rett-related disorders